Skip to main content

Dodge & Cox

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 200217 San Francisco, CA

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$3,444,613,008
-$103,177,841 QoQ
Shares Held
4,458,238
-3.0% QoQ
Ownership
4.25%
of shares outstanding
% of Portfolio
1.99%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Dodge & Cox holds $6,385,523,643 across 5 Biotechnology names. REGN ranks #1 (53.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
4,458,238 $3,444,613,008

All Filings in REGN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,444,613,008 4,458,238
2025-12-31 $3,547,790,849 4,596,358
2025-09-30 $2,558,803,618 4,550,845
2025-06-30 $2,008,798,575 3,826,283
2025-03-31 $1,474,004,429 2,324,085
2024-12-31 $1,653,543,026 2,321,316
2024-09-30 $2,430,398,549 2,311,935
2024-06-30 $2,433,855,456 2,315,686
2024-03-31 $2,271,345,501 2,359,864
2023-12-31 $2,079,509,667 2,367,680
2023-09-30 $1,952,882,434 2,372,998
2023-06-30 $1,720,439,841 2,394,355
2023-03-31 $1,959,437,270 2,384,701
2022-12-31 $1,603,914,837 2,223,059
2022-09-30 $1,575,107,454 2,286,509
2022-06-30 $1,339,106,887 2,265,334
2022-03-31 $1,562,409,540 2,237,063
2021-12-31 $176,271,125 279,122